Monsanto’s purchase includes the Agradis name and its collection of microbes that can improve crop productivity. Monsanto has also acquired the company’s R&D site in La Jolla, California (US). Additional details were not disclosed.
Steve Padgette, Monsanto R&D investment strategy lead, said: “Agradis’ collection of plant associated microbes will support Monsanto’s efforts to provide farmers with sustainable biological products to improve crop health and productivity.
“We value the expertise and capabilities the Agradis team brings to Monsanto as we continue to build on this exciting area of research.”
Source: Monsanto
© FoodBev Media Ltd 2024